搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella paratyphi B Probable intracellular septation protein A (yciB) CSB-YP433082STF
CSB-EP433082STF
CSB-BP433082STF
CSB-MP433082STF
CSB-EP433082STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP433083STF
CSB-EP433083STF
CSB-BP433083STF
CSB-MP433083STF
CSB-EP433083STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B tRNA sulfurtransferase (thiI) CSB-YP433084STF
CSB-EP433084STF
CSB-BP433084STF
CSB-MP433084STF
CSB-EP433084STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Recombination-associated protein rdgC (rdgC) CSB-YP433085STF
CSB-EP433085STF
CSB-BP433085STF
CSB-MP433085STF
CSB-EP433085STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Multidrug resistance protein MdtL (mdtL), partial CSB-YP433086STF
CSB-EP433086STF
CSB-BP433086STF
CSB-MP433086STF
CSB-EP433086STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Aspartate--ammonia ligase (asnA) CSB-YP433087STF
CSB-EP433087STF
CSB-BP433087STF
CSB-MP433087STF
CSB-EP433087STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Low affinity potassium transport system protein kup (kup), partial CSB-YP433088STF
CSB-EP433088STF
CSB-BP433088STF
CSB-MP433088STF
CSB-EP433088STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG) CSB-YP433089STF
CSB-EP433089STF
CSB-BP433089STF
CSB-MP433089STF
CSB-EP433089STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Gamma-glutamyl phosphate reductase (proA) CSB-YP433090STF
CSB-EP433090STF
CSB-BP433090STF
CSB-MP433090STF
CSB-EP433090STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Protein CyaY (cyaY) CSB-YP433091STF
CSB-EP433091STF
CSB-BP433091STF
CSB-MP433091STF
CSB-EP433091STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Na (+)/H (+) antiporter nhaA, partial CSB-YP433092STF
CSB-EP433092STF
CSB-BP433092STF
CSB-MP433092STF
CSB-EP433092STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Protein fixA (fixA) CSB-YP433093STF
CSB-EP433093STF
CSB-BP433093STF
CSB-MP433093STF
CSB-EP433093STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Gamma-aminobutyraldehyde dehydrogenase (prr) CSB-YP433094STF
CSB-EP433094STF
CSB-BP433094STF
CSB-MP433094STF
CSB-EP433094STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B D-tyrosyl-tRNA (Tyr) deacylase CSB-YP433095STF
CSB-EP433095STF
CSB-BP433095STF
CSB-MP433095STF
CSB-EP433095STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B L-rhamnose isomerase (rhaA) CSB-YP433096STF
CSB-EP433096STF
CSB-BP433096STF
CSB-MP433096STF
CSB-EP433096STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B CDP-diacylglycerol pyrophosphatase (cdh), partial CSB-YP433097STF
CSB-EP433097STF
CSB-BP433097STF
CSB-MP433097STF
CSB-EP433097STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Autoinducer 2 import ATP-binding protein LsrA (lsrA), partial CSB-YP433098STF
CSB-EP433098STF
CSB-BP433098STF
CSB-MP433098STF
CSB-EP433098STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Cell division protein ZapB (zapB) CSB-YP433099STF
CSB-EP433099STF
CSB-BP433099STF
CSB-MP433099STF
CSB-EP433099STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B 2-isopropylmalate synthase (leuA), partial CSB-YP433100STF
CSB-EP433100STF
CSB-BP433100STF
CSB-MP433100STF
CSB-EP433100STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi B Sugar fermentation stimulation protein A (sfsA) CSB-YP433101STF
CSB-EP433101STF
CSB-BP433101STF
CSB-MP433101STF
CSB-EP433101STF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>